Limor Kohen - Gefen Biomed Insider |
Gefen Biomed Investments Ltd -- Israel Stock | null 4.80 0.00 0.00% |
CEO of the Company and of some of its Subsidiaries
Ms. Limor Kohen was appointed Director at Gefen Biomed Investments Ltd, in addition to her roles of Chief Executive Officer of the Company and of some of its Subsidiaries, effective August 29, 2017. Her work experience includes the following roles Chief Executive Officer at the Company, Director at the Company, Chief Executive Officer of some Subsidiaries of the Company, Deputy Chief Executive Officer at the Company, Vice PresidentSales at Eurocom and Managing Director at Treatec 21 Industries Ltd . She holds a Bachelor of Business Administration degree, majoring in Finance and Marketing, from Hamichlala Leminhal.
Age: 52 CEO Since 2017
972 8 675 1122 http://www.gefenbiomed.com
Management Efficiency
The company has return on total asset (ROA) of 20.33 % which means that it generated profit of $20.33 on every $100 spent on asset. This is normal as compared to the sector avarege.The company has accumulated 20.23 M in total debt with debt to equity ratio (D/E) of 0.49 which is about average as compared to similar companies. Gefen Biomed Investments Ltd has Current Ratio of 0.58 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Similar Executives
Found 11 records | CEO Since | |
Itamar Regev | Mega Or Holdings Ltd | 2011 |
Doron Turgeman | B Communications Ltd | 2011 |
Stella Handler | B Communications Ltd | 2010 |
Ilan Toker | Arad Investment Industrial Deve | 2011 |
Daniel Zalkind | Electra Consumer Products Ltd | 2008 |
Sason Sinay | Inrom Construction Industries L | 2007 |
Eldad Moshe | Inrom Construction Industries L | 2014 |
Gadi Elikam | Sella Capital Real Estate Ltd | 2010 |
Doron Sela | Electra Consumer Products Ltd | 2014 |
Thomas Hardy | Inrom Construction Industries L | 2001 |
Oded Frenkel | Inrom Construction Industries L | 2006 |
Entity Summary
Gefen Biomed Investments Ltd engages in the location, screening, and investment in earlystage medical devices and biotechnology companies. Gefen Biomed Investments Ltd (GEFEN) is traded on Tel Aviv Stock Exchange in Israel. It is located in Ashkelon, and employs 12 people.Gefen Biomed Investments Leadership Team
Limor Kohen, CEO | |
Efrat Romano, Director | |
BenZion Weiner, Director | |
Moshe Talbi, Executive | |
Gal Dikshtein, Director, MBA | |
Guy Rosen, Director | |
Uri BenOr, President, MBA | |
Roi Kalmar, Executive | |
Ahuva Brand, Director | |
Meir Rock, Director, Ph.D | |
David Grossman, Director | |
Samuel Baklache, Director | |
Hila Kiron, Director | |
Meni More, CEO | |
Yair Fudim, Director, MBA | |
Elad Nagar, Director | |
Anit Portman, CFO | |
Miri Sharir, Director, MBA | |
Tali Biron, Executive | |
Hezi Sidon, Director | |
Beny Sidon, President | |
Dan Zeskind, Director |
Stock Performance Indicators
Shares Outstanding | 6.87 M |
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
View All Next | Launch Companies Directory |
Tel Aviv Stock Exchange Efficient Frontier
Diversify in Israel Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.You can create optimal portfolios in Israel market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify PortfoliosPlease also check Risk vs Return Analysis. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.